EXCLUSIVE: AlphaGene Puts Itself Up for Sale | GenomeWeb

NEW YORK, May 14 - AlphaGene is up for sale, an executive at the company told GenomeWeb today.

"We are in the process of selling the company," said Donald McCarren, president and CEO of the privately held functional genomics firm. "We don't have the resources to fully develop the value inside the company."

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: convergent evolution in bird hemoglobin, and more.

The Wall Street Journal speaks with patients affected by questionable test results from Theranos.

Researchers link variants in TACR3 to hot flashes during menopause, Live Science reports.

Kuwait says it will alter its law requiring citizens and visitors to provide DNA samples, New Scientist reports.